Sentry LLC’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
3,124
+30
+1% +$11.1K 0.34% 39
2026
Q1
$906K Sell
3,094
-31
-1% -$10.2K 0.29% 46
2025
Q4
$1.1M Hold
3,125
0.3% 40
2025
Q3
$1.01M Sell
3,125
-44
-1% -$13.7K 0.25% 41
2025
Q2
$1.23M Sell
3,169
-20
-0.6% -$8.04K 0.25% 34
2025
Q1
$1.39M Buy
3,189
+146
+5% +$58.6K 0.27% 29
2024
Q4
$1.12M Sell
3,043
-166
-5% -$69.5K 0.22% 35
2024
Q3
$1.67M Buy
3,209
+30
+0.9% +$16K 0.32% 24
2024
Q2
$1.72M Sell
3,179
-30
-0.9% -$15.9K 0.32% 22
2024
Q1
$1.66M Hold
3,209
0.31% 23
2023
Q4
$1.51M Hold
3,209
0.32% 24
2023
Q3
$1.4M Sell
3,209
-66
-2% -$29.9K 0.29% 24
2023
Q2
$1.45M Sell
3,275
-29
-0.9% -$13.4K 0.32% 23
2023
Q1
$1.52M Buy
+3,304
New +$1.57M 0.36% 23

Other funds holding ELV

Sentry LLC's ELV Position: Q2 2026 in Review

Sentry LLC increased its Elevance Health (ELV) stake by 0.97% in Q2 2026, buying an estimated $11.1K and bringing the position to 3,124 shares worth $1.21M. The position accounts for 0.34% of the portfolio, ranked #39.

Sentry LLC first reported a position in ELV in Q1 2023 and has held it in 14 quarters since. The position peaked at $1.72M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Sentry LLC held 3,124 shares of Elevance Health worth $1.21M as of Q2 2026.
  • Sentry LLC bought 30 Elevance Health shares in Q2 2026, an estimated $11.1K.
  • Elevance Health made up 0.34% of Sentry LLC's portfolio in Q2 2026, its #39 holding.
  • Sentry LLC first reported a position in Elevance Health in Q1 2023 and has held it in 14 quarters since.
  • Sentry LLC's Elevance Health position peaked at $1.72M in Q2 2024.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Sentry LLC's 13F filing for Q2 2026, filed 14 Aug 2026.